Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.
2.

Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis.

Jarratt MT, Clark SD, Savin RC, Swinyer LJ, Safley CF, Brodell RT, Yu K.

Cutis. 2006 Nov;78(5):348-54.

PMID:
17186795
3.
4.

Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial.

Sofen H, Hudson CP, Cook-Bolden FE, Preston N, Colón LE, Colón LE, Caveney SW, Gottschalk RW.

J Drugs Dermatol. 2011 Aug;10(8):885-92.

PMID:
21818510
5.

Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasis.

Menter MA, Caveney SW, Gottschalk RW.

J Drugs Dermatol. 2012 Nov;11(11):1348-54. Review.

PMID:
23135087
6.

Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.

Decroix J, Pres H, Tsankov N, Poncet M, Arsonnaud S.

Cutis. 2004 Sep;74(3):201-6.

PMID:
15499763
7.
8.
9.

Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.

Jarratt M, Breneman D, Gottlieb AB, Poulin Y, Liu Y, Foley V.

J Drugs Dermatol. 2004 Jul-Aug;3(4):367-73.

PMID:
15303780
10.

Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis.

Mazzotta A, Esposito M, Carboni I, Schipani C, Chimenti S.

J Dermatolog Treat. 2007;18(2):84-7.

PMID:
17520464
11.
12.

A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.

Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, Feldman SR.

Int J Dermatol. 2002 May;41(5):269-74.

PMID:
12100701
13.

A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.

Lebwohl MG, Kircik L, Callis Duffin K, Pariser D, Hooper M, Wenkert D, Thompson EH, Yang J, Kricorian G, Koo J.

J Am Acad Dermatol. 2013 Sep;69(3):385-92. doi: 10.1016/j.jaad.2013.03.031. Epub 2013 May 1.

PMID:
23643256
14.
15.
16.
17.
18.

Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.

Austad J, Bjerke JR, Gjertsen BT, Helland S, Livden JK, Morken T, Mørk NJ.

J Eur Acad Dermatol Venereol. 1998 Jul;11(1):19-24.

PMID:
9731961
19.
20.

The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.

Housman TS, Keil KA, Mellen BG, McCarty MA, Fleischer AB Jr, Feldman SR.

J Am Acad Dermatol. 2003 Jul;49(1):79-82.

PMID:
12833013

Supplemental Content

Support Center